S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
NASDAQ:STAA

STAAR Surgical - STAA Earnings Date, Estimates & Call Transcripts

$82.89
-4.83 (-5.51%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$81.35
$87.70
50-Day Range
$62.10
$87.72
52-Week Range
$49.03
$163.08
Volume
376,958 shs
Average Volume
470,963 shs
Market Capitalization
$3.96 billion
P/E Ratio
142.92
Dividend Yield
N/A
Price Target
$92.00

Earnings Summary

Upcoming
Earnings Date
Aug. 10Confirmed
Actual EPS
(May. 4)
$0.21 Beat By $0.11
Consensus EPS
(May. 4)
$0.10
Last Year's Q2 EPS
(5/5/2021)
$0.20
Skip Charts & View Estimated and Actual Earnings Data

STAA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

STAA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

STAAR Surgical Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20221$0.19$0.19$0.19 
Q2 20222$0.19$0.21$0.20 
Q3 20222$0.15$0.23$0.19 
Q4 20222$0.14$0.23$0.19 
FY 20227$0.67$0.86$0.77 
Q1 20231$0.17$0.17$0.17 
Q2 20231$0.32$0.32$0.32 

STAA Earnings Date and Information

STAAR Surgical last issued its earnings results on May 4th, 2022. The medical instruments supplier reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.11. The firm earned $63.20 million during the quarter, compared to analysts' expectations of $60.53 million. Its revenue for the quarter was up 24.5% compared to the same quarter last year. STAAR Surgical has generated $0.58 earnings per share over the last year ($0.58 diluted earnings per share) and currently has a price-to-earnings ratio of 142.9. Earnings for STAAR Surgical are expected to grow by 72.31% in the coming year, from $0.65 to $1.12 per share. STAAR Surgical has confirmed that its next quarterly earnings report will be published on Wednesday, August 10th, 2022. STAAR Surgical will be holding an earnings conference call on Wednesday, August 10th at 4:30 PM Eastern. Interested parties can register for or listen to the call. or dial in at 929-458-6194 with passcode "944172".

STAAR Surgical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/10/2022
(Confirmed)
 $0.25       
5/4/2022Q1 2022$0.10$0.21+$0.11$0.23$60.53 million$63.20 million    
2/23/2022Q4 2021$0.10$0.12+$0.02$0.14$59.21 million$59.00 million    
11/3/20219/30/2021$0.11$0.12+$0.01$0.14$57.70 million$58.35 million    
8/3/20216/30/2021$0.03$0.17+$0.14$0.21$52.61 million$62.37 million    
5/5/20213/31/2021($0.02)$0.20+$0.22$0.16$43.50 million$50.75 million  
2/23/202112/31/2020$0.09$0.14+$0.05$0.21$45.40 million$46.00 million  
11/9/20209/30/2020$0.09$0.14+$0.05$0.20$42.99 million$47.10 million  
8/5/20206/30/2020$0.04$0.03($0.01)$0.09$37.60 million$35.19 million  
5/6/20203/31/2020$0.03$0.04+$0.01$0.08$34.90 million$35.19 million  
2/26/2020Q4 2019$0.03$0.12+$0.09$0.10$39.10 million$38.88 million  
10/30/2019Q3 2019$0.05$0.05$0.19$37.50 million$39.06 million  
7/31/2019Q2$0.10$0.14+$0.04$0.20$40.10 million$39.66 million
5/1/20193/31/2019$0.04$0.10+$0.06$0.17$32.40 million$32.58 million
2/21/201912/31/2018$0.01$0.02+$0.01$0.12$31.20 million$31.19 million
10/31/20189/30/2018($0.03)$0.03+$0.06$0.11$30.10 million$31.77 million
8/1/2018Q2 2018$0.01$0.09+$0.08$0.14$27.10 million$33.91 million
5/2/2018Q1 2018($0.04)$0.04+$0.08$0.07$23.00 million$27.09 million  
2/28/2018Q4 2017$0.03$0.02($0.01)$0.04$24.85 million  
11/8/2017Q3 2017$0.02$0.02$0.01$23.47 million
8/2/2017Q2 2017($0.01)($0.01)$22.15 million$21.90 million  
5/3/2017Q1 2017($0.0530)($0.05)+$0.0030($0.05)$20.35 million  
3/2/2017Q4 2016$0.01+$0.01$0.02$22.25 million$22.10 million  
11/3/2016Q3 2016($0.03)($0.03)($0.02)$20.70 million$20.05 million  
8/3/2016Q2 2016($0.03)($0.03)($0.01)$19.88 million$21.00 million  
5/11/2016Q1 2016($0.01)($0.01)$0.18$19.60 million$19.30 million  
3/2/2016Q415($0.02)$0.01+$0.03$19.11 million$20.90 million  
10/28/2015Q3 2015($0.02)($0.02)$17.87 million$18.80 million  
7/29/2015Q2 2015($0.02)($0.02)$18.20 million$18.66 million
4/29/2015Q115($0.04)$0.03+$0.07$17.85 million$18.90 million  
2/25/2015Q4 2014($0.04)($0.04)($0.01)$16.60 million$16.60 million  
10/30/2014Q3 2014($0.04)($0.04)($0.01)$19.53 million$18.20 million  
7/31/2014Q2 2014($0.03)($0.03)($0.01)$19.80 million$20.05 million  
4/28/2014Q114$0.01$0.04+$0.03$19.44 million$20.20 million  
2/26/2014Q4 2013($0.01)($0.01)$18.98 million$18.90 million  
10/30/2013Q3 2013$0.02+$0.02$0.03$17.35 million$17.10 million  
7/31/2013Q2 2013$0.03+$0.03$0.05$17.40 million$18.20 million  
5/1/2013Q1 2013$0.04+$0.04$0.07$17.27 million$18.00 million  
2/27/2013Q4 2012$0.03$0.01($0.02)$17.55 million$16.50 million  
10/31/2012Q312$0.01$0.04+$0.03$16.78 million$15.90 million
8/1/2012$0.03$0.03
5/2/2012$0.03$0.04+$0.01
3/6/2012Q4 2011$0.02$0.02$0.04
10/24/2011Q3 2011$0.02$0.01($0.01)$0.02
8/2/2011Q2 2011$0.01$0.02+$0.01$0.02
5/3/2011Q1 2011$0.01+$0.01$0.01
3/1/2011Q4 2010$0.01($0.02)($0.03)($0.02)
11/2/2010Q3 2010$0.01($0.03)($0.04)($0.03)
8/3/2010Q2 2010($0.02)($0.02)$0.01
5/4/2010Q1 2010($0.01)($0.02)($0.01)($0.14)
3/2/2010Q4 2009($0.03)($0.06)($0.03)$0.15
11/2/2009Q3 2009($0.03)($0.05)($0.02)($0.04)
8/3/2009Q2 2009($0.01)($0.04)($0.03)($0.04)
5/5/2009Q1 2009($0.05)$0.02+$0.07$0.10
3/16/2009Q4 2008($0.04)($0.12)($0.08)$0.08
10/28/2008Q3 2008($0.07)($0.08)($0.01)($0.08)
7/30/2008Q2 2008($0.10)($0.09)+$0.01($0.09)
5/6/2008Q1 2008($0.12)($0.30)($0.18)($0.30)
3/6/2008Q4 2007($0.10)($0.15)($0.05)($0.15)












STAAR Surgical Earnings - Frequently Asked Questions

When is STAAR Surgical's earnings date?

STAAR Surgical has confirmed that its next quarterly earnings data will be published on Wednesday, August 10th, 2022. Learn more on STAA's earnings history.

Did STAAR Surgical beat their earnings estimates last quarter?

In the previous quarter, STAAR Surgical (NASDAQ:STAA) reported $0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $0.10 by $0.11. Learn more on analysts' earnings estimate vs. STAA's actual earnings.

How can I listen to STAAR Surgical's earnings conference call?

The conference call for STAAR Surgical's latest earnings report can be listened to online. Listen to Conference Call

How can I read STAAR Surgical's conference call transcript?

The conference call transcript for STAAR Surgical's latest earnings report can be read online. Read Transcript

How much revenue does STAAR Surgical generate each year?

STAAR Surgical (NASDAQ:STAA) has a recorded annual revenue of $230.47 million.

How much profit does STAAR Surgical generate each year?

STAAR Surgical (NASDAQ:STAA) has a recorded net income of $24.50 million. STAA has generated $0.58 earnings per share over the last four quarters.

What is STAAR Surgical's price-to-earnings ratio?

STAAR Surgical (NASDAQ:STAA) has a trailing price-to-earnings ratio of 142.92 and a forward price-to-earnings ratio of 127.52.

What is STAAR Surgical's EPS forecast for next year?

STAAR Surgical's earnings are expected to grow from $0.65 per share to $1.12 per share in the next year, which is a 72.31% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:STAA) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.